Cost-effectiveness analysis: Developing nations left behind

PharmacoEconomics

Volumn 26, Issue 5, 2008, Pages 359-361

  Singer, Mendel E ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cost effectiveness

Indexed keywords

CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; EDITORIAL; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; ECONOMICS, PHARMACEUTICAL;

EID: 42449131724     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200826050-00001     Document Type: Editorial

References (5)

1. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977; 296: 716-21
2. Singer ME, Applegate KE. Cost-effectiveness analysis in radiology. Radiology 2001; 219: 611-20
3. Commission on Macroeconomics and Health. Macroeconomics and health: investing in health for economic development. Geneva: WHO, 2001
4. Goldie SJ, Yazdanpanah Y, Losina E, et al. Cost-effectiveness of HIV treatment in resource-poor settings: the case of Cote d'Ivoire. N Engl J Med 2006; 355 (11): 1141-53
5. Murray CJL, Lauer JA, Hutubessy RCW, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361 (9359): 717-25